MiNK Therapeutics, Inc. (INKT)
USD 0.46
(-14.02%)
USD 0.46
(-14.02%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -15.76 Million | -18.86 Million | -12.82 Million | -8.33 Million | -14.94 Million |
| Net Income | -22.45 Million | -27.99 Million | -30.21 Million | -16.23 Million | -23.8 Million |
| Depreciation & Amortization | 204.61 Thousand | 121.74 Thousand | 77.96 Thousand | 55.06 Thousand | 36.81 Thousand |
| Deferred income taxes | -3.86 Billion | - | -355.51 Thousand | - | - |
| Stock-based compensation | 3.86 Million | 3.02 Million | 1.74 Million | 87.82 Thousand | 219.57 Thousand |
| Change in working capital | 2.89 Million | 8.76 Million | 3.73 Million | -324.93 Thousand | 4.11 Million |
| Other non-cash items | 3.86 Billion | -2.79 Million | 12.18 Million | 8.08 Million | 4.48 Million |
| Investing Cash Flow | -73.56 Thousand | -250.04 Thousand | -248.98 Thousand | -95.21 Thousand | -426.46 Thousand |
| Investments in PPE | -73.56 Thousand | -250.04 Thousand | -248.98 Thousand | -95.21 Thousand | -426.46 Thousand |
| Acquisitions | - | - | - | - | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | -73.56 Million | -250.04 Million | -248.98 Million | - | - |
| Financing Cash Flow | -407.17 Thousand | -155.59 Thousand | 49.25 Million | 11.1 Million | 11.43 Million |
| Debt repayment | - | - | -9.45 Million | -11.1 Million | -11.43 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | -477.63 Thousand | -157.19 Thousand | - | - | - |
| Common Stock Issuance | 70.46 Thousand | 293.52 Million | 39.79 Million | 901.00 | - |
| Other Financing Activities | -477.63 Thousand | -293.52 Million | 18.91 Million | 22.21 Million | 22.87 Million |
| Accounts receivables | - | - | - | 1.8 Million | 3.43 Million |
| Accounts payables | -1.91 Million | 2.66 Million | -152.04 Thousand | 607.85 Thousand | 886.66 Thousand |
| Inventory | - | - | - | -1.8 Million | -3.43 Million |
| Other working capital | 4.81 Million | 6.1 Million | 3.88 Million | -932.78 Thousand | 3.22 Million |
| Cash at beginning of period | 19.63 Million | 38.88 Million | 2.69 Million | 299.03 Thousand | 4.35 Million |
| Cash at end of period | 3.36 Million | 19.63 Million | 38.88 Million | 2.69 Million | 299.03 Thousand |
| Capital Expenditure | -73.56 Thousand | -250.04 Thousand | -248.98 Thousand | -95.21 Thousand | -426.46 Thousand |
| Effect of forex changes on cash | -25.25 Thousand | 19.38 Thousand | 16.89 Thousand | -281.17 Thousand | -122.07 Thousand |
| Net cash flow / Change in cash | -16.26 Million | -19.25 Million | 36.19 Million | 2.39 Million | -4.05 Million |
| Free Cash Flow | -15.83 Million | -19.11 Million | -13.07 Million | -8.43 Million | -15.37 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.7 Million | -3.81 Million | -5.45 Million | -22.45 Million | -5.11 Million | -6.19 Million |
| Depreciation & Amortization | 45.1 Thousand | 53.83 Thousand | 53.57 Thousand | 204.61 Thousand | 53.45 Thousand | 51.9 Thousand |
| Deferred income taxes | - | - | -1.58 Million | -3.86 Billion | 939 Thousand | - |
| Stock-based compensation | 436.87 Thousand | 592 Thousand | 1.1 Million | 3.86 Million | 939.26 Thousand | 898.26 Thousand |
| Change in working capital | -79.63 Thousand | 620.8 Thousand | 1.26 Million | 2.89 Million | -85.59 Thousand | 1.36 Million |
| Other non-cash items | 820.63 Thousand | 1.12 Million | 1.58 Million | 3.86 Billion | -939 Thousand | -266.78 Thousand |
| Investing Cash Flow | - | - | -73.48 Million | -73.56 Thousand | -23.04 Thousand | -37.01 Thousand |
| Investments in PPE | - | - | 73.56 Thousand | -73.56 Thousand | -23.04 Thousand | -37.01 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -73.56 Million | -73.56 Million | - | - |
| Financing Cash Flow | 5.8 Million | 5 Million | -2.00 | -407.17 Thousand | 2952.00 | -75.69 Thousand |
| Debt repayment | - | -5 Million | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -2.00 | -477.63 Thousand | 2.00 | -97.71 Thousand |
| Common Stock Issuance | 5.8 Million | 6896.00 | 285.07 Million | 70.46 Thousand | 2950.00 | 22.02 Thousand |
| Other Financing Activities | 6288.00 | 4.87 Billion | -2.00 | -477.63 Thousand | 2.00 | -97.71 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -284.77 Thousand | -424.43 Thousand | -373.34 Thousand | -1.91 Million | -578.3 Thousand | -1.11 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 205.14 Thousand | 1.04 Million | 1.64 Million | 4.81 Million | 492.71 Thousand | 2.48 Million |
| Cash at beginning of period | 5.81 Million | 3.36 Million | 6.39 Million | 19.63 Million | 10.62 Million | 14.89 Million |
| Cash at end of period | 9.31 Million | 5.81 Million | 3.36 Million | 3.36 Million | 6.39 Million | 10.62 Million |
| Capital Expenditure | - | - | 73.56 Thousand | -73.56 Thousand | -23.04 Thousand | -37.01 Thousand |
| Effect of forex changes on cash | -19.02 Thousand | -14.83 Thousand | 4309.00 | -25.25 Thousand | 5905.00 | -6124.00 |
| Net cash flow / Change in cash | 3.49 Million | 2.44 Million | -3.03 Million | -16.26 Million | -4.22 Million | -4.26 Million |
| Free Cash Flow | -2.29 Million | -2.54 Million | -2.96 Million | -15.83 Million | -4.23 Million | -4.18 Million |
CG
BUR
HFR
BYDGF
KEY-PI
9956